Your session is about to expire
← Back to Search
Diagnostic Software for Pediatric Rheumatology
N/A
Waitlist Available
Led By Robert P Sundel, MD
Research Sponsored by PhenoSolve, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
Study Summary
This trialtests a software to help diagnose pediatric rheumatic diseases. Trainees and nurses compare their diagnoses to attending doctors and the final diagnosis.
Who is the study for?
This trial is for trainees, including rheumatology and rotating fellows, as well as nurse practitioners working in Rheumatology. It's designed to see if a diagnostic support tool helps them diagnose pediatric rheumatic diseases more accurately.Check my eligibility
What is being tested?
The study tests the SimulConsult diagnostic software by comparing diagnoses made with it by trainees and nurse practitioners against those of experienced attending physicians and definitive diagnoses confirmed later on.See study design
What are the potential side effects?
Since this trial involves a diagnostic decision support software rather than medication or invasive procedures, there are no direct physical side effects associated with its use.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Performance against Gold Standard: Presence of Gold standard #1 diagnosis in trainee list
Secondary outcome measures
Performance against definitive diagnosis: Presence of definitive diagnosis in trainee list
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention (Use of diagnostic decision support software)Experimental Treatment1 Intervention
Trainee or nurse practitioner sees patient and uses diagnostic decision support software in developing their differential diagnosis and plan
Group II: Control (Current process)Active Control1 Intervention
Trainee or nurse practitioner sees patient but doesn't use diagnostic decision support software in developing their differential diagnosis and plan
Find a Location
Who is running the clinical trial?
PhenoSolve, LLCLead Sponsor
3 Previous Clinical Trials
138 Total Patients Enrolled
Boston Children's HospitalOTHER
761 Previous Clinical Trials
5,579,715 Total Patients Enrolled
Robert P Sundel, MDPrincipal InvestigatorBoston Children's Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Control (Current process)
- Group 2: Intervention (Use of diagnostic decision support software)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is eligibility for this clinical trial open to me?
"Those with collagen diseases and ages ranging between eighteen to sixty-five may be admitted into this clinical trial, which is seeking out 15 volunteers in total."
Answered by AI
Are participants of this study restricted to those under 50 years in age?
"This medical study is open to those above the age of consent, yet below 65 years old."
Answered by AI
Are investigators currently accepting new participants for this research study?
"The clinicaltrials.gov registry indicates that this trial, which was initiated on April 20th 2021 and last updated September 30th 2022 is no longer enrolling participants. However, there are presently 1 other trials actively seeking volunteers."
Answered by AI
Share this study with friends
Copy Link
Messenger